Dr. Bastiaan B.J. Tops goal is to change how we diagnose childhood cancer.
In this session, he reveals how Oxford Nanopore methylation profiling could bring clarity to complex paediatric tumours, potentially delivering answers faster than current methods. https://bit.ly/4d50nWl
Don’t Jason Hendry at #ESCMID to uncover how they are surveying malaria in real-time. Using portable Oxford Nanopore technology in the field, this work is bringing actionable insights closer to communities and public health teams who need it most. https://bit.ly/4uQNpSw
Transform your targeting sequencing assays on P2i with digital panels for on-device target selection, powered by Adaptive Sampling.
Learn more: https://bit.ly/40HYiIB
Traditional cultures are slow. In >100 bacterial samples, Oxford Nanopore sequencing delivered faster, lower-cost and more accurate pathogen detection than the standard of care — enabling rapid, actionable insights.
Learn more: https://bit.ly/4sudRQ2
Preparing your flow cell, adding your sample, and kicking off your sequencing experiment is fast and simple. In this Nanopore Know-How blog, we’ll walk you through the process. https://bit.ly/4sy85Nl
Cost-effectiveness is often determined by upfront costs. But getting to the right results faster could eliminate downstream interventions — saving time & money while improving outcomes. Mike shares how Oxford Nanopore has the potential to do this. https://bit.ly/47nLgDy
A new method may finally unlock answers for rare diseases long considered unsolvable. Read how researchers interpreted splicing variants from unresolved disease cases, identifying rich information missed through previous screening. https://bit.ly/483xQNm
In her #ESCMID talk, Sofia Brunet will share how routine bacterial identification in Sweden is becoming faster and more confident. Discover how Oxford Nanopore 16S sequencing is supporting this with rapid, accurate, actionable microbial insights. https://bit.ly/41oHO8g
Unmatched speed. Rich data. Nanopore sequencing eliminates the limits of traditional methylation detection. No bias, ultra-long reads, and straightforward library prep.
Don’t compromise. What you’re missing matters. #WYMM
Learn more in our guide: https://bit.ly/3Md9j0L
At #ESMID, hear Jose Alexander share how Oxford Nanopore sequencing is helping clinical microbiology labs move beyond traditional limits and respond more effectively to antimicrobial resistance. Learn more: https://bit.ly/40Oy4nK
Struggling to get complete microbial genomes at scale?
Join the webinar to see how a nanopore‑only solution delivers reference‑quality assemblies — resolving plasmids, repeats and AMR genes in a single workflow. https://bit.ly/4lElUYe
When you need a multiomic view to see the bigger picture, P2i is the fully integrated sequencer you can count on for greater insights into human health and disease. Ask more of your sequencing. Find out more: https://bit.ly/4sACA51
Don’t miss leading voices in cancer at #Nanoporeconf sharing breakthroughs reshaping how we understand and, in the future, treat the disease. From rapid tumour profiling to scalable clinical genomics, hear the research improving cancer outcomes globally. https://bit.ly/4ca2k1J
Join us at London Calling 2026! Take this exciting opportunity to connect with some of the brightest minds in the field and explore the latest breakthroughs in Oxford Nanopore sequencing.
Want to attend as a team? Buy three, get one FREE. Tickets here: https://bit.ly/4sS0I3f #nanoporeconf
A new method may finally unlock answers for rare diseases long considered unsolvable. Read how researchers from UCL interpreted splicing variants from unresolved disease cases, identifying rich information missed through previous screening. Read here: https://bit.ly/4lNWszn
Martin shares how they are accurately sequencing data at scale, enabling the team to spend less time at the bench and more time on what really matters. Learn what you’re missing in this real talk with researchers: https://bit.ly/3MlTe9f
From population genomics to clinical impact, London Calling spotlights science that matters. Hear advances in epigenetics, paediatric cancer, pathogens, multiomics, and bioinformatics. Connect, learn, and help shape the future. Register now. https://bit.ly/40RyBW2 #Nanoporeconf
When outbreaks spread fast, time to answer matters as much as the answer itself.
Join us at #ESCMID to hear how researchers are making faster, more informed, and more impactful decisions using Oxford Nanopore sequencing for rapid, rich microbial insights. https://bit.ly/3NBP4uo
Lucia utilises Oxford Nanopore sequencing for methylation insights at single-nucleotide resolution, providing robust data she can rely on. Learn more about researchers unlocking data they can trust: https://bit.ly/4u4qqTJ #SwitchON
This is ORG one
Learn more: ORG.one
London Calling 2026 is less than months away! Discover our exciting agenda with a wide range of speakers sharing innovative approaches and unlocking novel biology with Oxford #Nanopore technology. #Nanoporeconf
Learn more here: https://bit.ly/46VeB85
Consistency matters when you’re trying to piece together answers to questions that have been unsolved for years. Nate shares how they have overcome inherent data analysis issues to accelerate their journey characterising rare diseases.
Learn more: https://bit.ly/4qNJfYa
Research use only.
Day 4 - part 2 AMR of Bacterial Pathogens - Africa course #AMRBactcourse on the sequencing practical with Nanopore led by @effkay88.bsky.social Huge thanks to the team from @nanoporetech.com South Africa @eventswcs.bsky.social @sangerinstitute.bsky.social
We’re partnering with A.D.A.M Innovations to bring a single, multiomic solution to identify rare diseases in Japan. Learn how this scalable platform will provide rapid, richer data and the potential for future expansion into other applications. https://bit.ly/4cNtflP
From plasmids to AMR genes — resolve it all in one workflow.
In this webinar, discover the updated NO-MISS microbial isolate sequencing workflow, now supporting PromethION for high-throughput projects. https://bit.ly/4uyuyLF
Learn more about adaptive sampling in our latest #Nanopore Know-How: nanoporetech.com/blog/guided-by-data-adap... #ACMGtg26
Cancer patients with lung infections don’t have time. Read how researchers used Oxford Nanopore sequencing to deliver faster and more precise pathogen detection than alternative sequencing methods, with the potential to inform more targeted treatment. https://bit.ly/4aQowgE
24 hours. One genome. Real impact.
See how rapid whole‑genome Oxford Nanopore sequencing could accelerate clinical research in NICUs — because when time matters, answers can’t wait.
Watch the webinar: https://bit.ly/4dcSiPe #ACMGtg26
For Research Use Only.
A major milestone for viral safety testing. Today, ViruSure launches the first GMP‑validated test using Oxford Nanopore sequencing — bringing broader detection, faster answers, and new confidence to biopharma QC. https://bit.ly/4umceFE
At #ACMGtg26, Chad Pollard will share how they are unlocking methylation profiles behind disease with direct Oxford Nanopore sequencing. Join him to learn how these insights could transform how we research and identify rare genetic diseases. https://bit.ly/3OEPujV
